版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
ChinaHeartsurvey--CallforActionDayiHuPeople’sHospitalofPekingUniversity2021-4-11ThePrimaryCauseofDeath:Cardio-CerebralVascularDiseasesStroke10%5.5mCAD13%7.2mCancer12%7.1mTrauma9%5.2mInfection7%2.8mOther27%15.6mAIDS5%2.8mMalaria2%1.2mDiarrhea3%1.8mPerinatalfactors4%2.5mCOPD5%2.7mWorldHealthOrganization.AtlasofHeartDiseaseandStroke.20052MajorRiskFactorsforCAD:Hypertension,Hyperlipidemia,Hyperglycemia3Althoughtheemergenceofnewdrugsandthereleaseofmanyevidence-basedresearchoutcomesrecently,arethemortalityofcardio-cerebralvasculareventsfullyreduced?Althoughtheuseofinterventiontherapyanddrugsdramaticallyincreased,themortalityofcardio-cerebralvasculardiseasesisstillgoingupSource:Deathandriskfactors,epidemiology,trendanddistributioninChinese.PekingUnionMedicalCollegePress.Sep.2005.StandardMortality(1/10thousand)Mortalitytrendofcardio-cerebralvasculardiseaseinChinesebetween1985and2005CADCerebralvasculardisease5Cause:“Thetherapyisseparated〞6Cause:
Hyperglycemia—aneglectedriskfactorofCVDCVDRiskfactorFamilyFatnessSexDyslipidemiaHypertensionAgeHyperglycemiaSmoke7ChinaHeartSurvey:ContentBackgroundDiabetesisasdangerousasCADPatientswithCADareatthehighriskforhyperglycemiaDesignResultMeaning8DiabetesisasdangerousasCADHaffnerSMetal.NEnglJMed.1998;339:229-234.Events/100person-yrIncidenceofcardiovasculardiseaseduringseven-yearfollow-up(%)n=6918.8Nondiabeticsubjects\withoutpriorMINondiabeticsubjects\withpriorMIDiabeticsubjects\withoutpriorMIDiabeticsubjects\withpriorMIn=1304n=169n=8903.00.57.83.23.545.020.2P<0.001P<0.001MIDMDM&MI010203040509
AmericanHeartAssociation:
Diabetesiscardiovasculardisease
StevenHaffner:
ConcerneachdiabeticpatientasimportantaspatientswithMICirculation.1999;100:1134-46.10EHS〔EUROHeartSurvey〕ESCreportinSep.2004:Thesurveyinvolved110centresin25countriesrecruiting4961patientswithCAD2107wereadmittedonanacutebasisand2854hadanelectiveconsultation.Atenrolment,1524ofthesepatientswasknowntohavetype2diabetes,aFPGwasmeasuredintheremainingpatients,andanOGTTin1920ofthesepatients.TheEuroHeartSurveyondiabetesandtheheart,EuropeanHeartJournal(2004)25,1880–189011EuroHeartSurvey:classificationofglucometabolicstate〔n=4,961〕Acute
Elective29%22%31%3%15%34%22%30%4%10%NGTIFG〔6.1mmol/L〕IGTDiagnosedDMNewlydiagnosedDMTheEuroHeartSurveyondiabetesandtheheart,EuropeanHeartJournal(2004)25,1880–189012EuroHeartSurvey:themythWhatistheepidemicabouthyperglycemiainChinesepatientswithCAD?Isthestrategyforhyperglycemiadiagnosissuitabletosuchpatients?13ChinaHeartSurvey:contentBackgroundDiabetesisasdangerousasCADPatientswithCADareatthehighriskforhyperglycemiaDesignResultMeaning14ChinaHeartSurvey:designSubjects52hospitalsin7citiesinChinaparticipatedinthesurveyTimeFromJun.1sttoAug.31th20053513patientshospitalizedforCADwasrecruited
InclusioncriteriaCoronaryheartdiseaseChronicStableAnginaHealedmyocardialinfractionAcutecoronarysyndromeArrhythmiaandheartfailurewasexcluded15MethodOGTTwasmeasuredinallpatients,exceptforthepatientswithknowndiabetesOGTTwasunnecessaryforthepatientswhoseFPG>8mmol/Lintwotesting16ChinaHeartSurvey:flowchartPreviouslyknowndiabetesNewlydiagnoseddiabetes〔FPG〕Newlydiagnoseddiabetes〔FPG〕773OGTT420Previouslyknowndiabetes411,234Acuteadmission2,279Electiveadmission3,513random3,687screened733561,490
OGTTDa-YiHu,etal.EuropeanHeartJournal2006;27:2573-2579.17ChinaHeartSurvey:contentBackgroundDiabetesisasdangerousasCADPatientswithCADareatthehighriskforhyperglycemiaDesignResultMeaning18ChinaHeartSurvey:
77%ofpatientswithCADhadhyperglycemiaKnowndiabetesNewlydiagnoseddiabetes(FPG)NormalglucosePrediabetesNewlydiagnoseddiabetes(OGTT)33%3%23%24%17%n=3,51319WithouttheuseofOGTT,over80%ofnewlydiagnoseddiabetesandpre-diabeteswillremainundiagnosedNormalIFGIGTType2diabetes人群比例(%)OGTTOGTTFPGFPGAcuteSelective020406080100Percentage(%)missedmissed20ConclusionIntheenrolledpatients(n=3,513),thepercentageofhyperglycemia(includeddiabetesandpre-diabetes)wasabout80%Theprevalenceofdiabeteswas52.92%(n=1,859),ofwhich20.1%〔n=706〕wasnewlydiagnoseddiabetesTheprevalenceofpre-diabeteswas26.38%〔n=927),allwasnewlydiagnosedexceptedonepatient21IfFPGwasmeasuredalone,withouttheuseofOGTT80%of609newlydiagnoseddiabeticpatientswillremainundiagnosed70%
of926newlydiagnosedpre-diabeticpatientswillremainundiagnosed
75%ofnewlydiagnoseddiabeticandpre-diabeticpatientswillremainundiagnosedifFPGismeasuredalone.Conclusion22ChinaHeartSurvey:contentBackgroundDiabetesisasdangerousasCADPatientswithCADareatthehighriskforhyperglycemiaDesignResultMeaning23ChinaHeartSurvey:meaningCHSsoundthealertforourcardiologists,neurologistsandcardio-vascularsurgeons,indicatingthatweshouldconcernwhetherdysglycaemiaexistintheadmittedpatients.Asfarasdysgl
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 內(nèi)分泌科常用護(hù)理技術(shù)
- 生產(chǎn)車間紀(jì)律管理制度公告(3篇)
- 職業(yè)中學(xué)后勤管理制度(3篇)
- 餐飲收銀臺(tái)管理制度(3篇)
- 獸藥廠培訓(xùn)課件
- 《GA 730-2007警服材料 四件褲鉤》專題研究報(bào)告
- 中學(xué)教師職稱評(píng)定制度
- 養(yǎng)老院入住老人心理咨詢服務(wù)制度
- 企業(yè)員工培訓(xùn)與素質(zhì)發(fā)展制度
- 企業(yè)內(nèi)部控制規(guī)范制度
- DB51-T 401-2025 禾本科牧草栽培技術(shù)規(guī)程 黑麥草屬
- 企業(yè)負(fù)責(zé)人安全培訓(xùn)考試題庫(kù)
- 中國(guó)社會(huì)科學(xué)院中國(guó)邊疆研究所2026年非事業(yè)編制人員招聘?jìng)淇碱}庫(kù)附答案詳解
- 2026四川廣安安農(nóng)發(fā)展集團(tuán)有限公司第一批次招聘勞務(wù)派遣制人員15人筆試備考試題及答案解析
- 肯尼亞介紹全套課件
- 中國(guó)眼底病臨床診療指南2025年版
- 押題專輯十五:14道押題+精準(zhǔn)解題+14篇范文+點(diǎn)評(píng)遷移七年級(jí)語(yǔ)文上學(xué)期期末作文押題(新教材統(tǒng)編版)
- 2025年高職(中醫(yī)康復(fù)技術(shù))運(yùn)動(dòng)康復(fù)綜合測(cè)試題及答案
- 新種子法培訓(xùn)課件
- 2025年重癥三基考試試題及答案
- GB 6529-1986紡織品的調(diào)濕和試驗(yàn)用標(biāo)準(zhǔn)大氣
評(píng)論
0/150
提交評(píng)論